Nonetheless, even considering these limitations, our data strongly suggest that loss of MUC2 as well as aberrant expression of MUC5AC and especially of MUC6 are relevant prognostic indicators in CRC. This evidence concerns the gene MUC2 and colorectal carcinoma.